Capital Markets

A Law360 Capital Markets Group of the Year in 2021

Learn more

Fenwick is a market leader and one of the top law firms in the United States for representing leading technology and life sciences companies in their initial public offerings and other equity and debt offerings. We advise clients on traditional IPOs, as well as other innovative public offering structures, including special purpose acquisition company offerings (SPACs), direct listings and reverse mergers. Our team represents investor-backed startups and high-growth companies, as well as high-profile public companies, and works closely with many of the most active investment banking firms.


The firm led the market in direct listings launched in 2021, recognized as #1 issuer-side in direct listings in 2021 by deal count, according to Deal Point Data.

Fenwick’s team was named a Capital Markets Group of the Year by Law360 in 2021. In 2021, Chambers USA also honored Fenwick among California’s leading firms for capital markets.

"[Fenwick’s] strength is that it brings the full suite of skill sets a company would need, including strategic thought partnership, in-depth technical understanding of the law, attention to detail with respect to legal documents and timely service."

Chambers USA

2021 Edition

Recognition Recognition Recognition

Recognition Recognition Recognition

Recognition
Law 360

2021

Honored Fenwick as a Capital Markets Group of the Year

Chambers USA

2022

Ranked Fenwick among California's leading firms for capital markets

The Legal 500

2022

Recognized Fenwick among the United States’ leading firms for capital markets

Recognition
Law 360

2021

Honored Fenwick as a Capital Markets Group of the Year

Chambers USA

2022

Ranked Fenwick among California's leading firms for capital markets

The Legal 500

2022

Recognized Fenwick among the United States’ leading firms for capital markets

  • BILL
  • Coinbase
  • Compass
  • Facebook
  • Fitbit
  • GitLab
  • LendingClub
  • Nextdoor
  • Peloton Interactive
  • PubMatic
  • Remitly
  • SentinelOne
  • Upwork
  • UserTesting
  • Velo3D
  • Workday
  • ZipRecruiter

  • BILL
  • Coinbase
  • Compass
  • Facebook
  • Fitbit
  • GitLab
  • LendingClub
  • Nextdoor
  • Peloton Interactive
  • PubMatic
  • Remitly
  • SentinelOne
  • Upwork
  • UserTesting
  • Velo3D
  • Workday
  • ZipRecruiter

  • AnaptysBio
  • Day One Biopharmaceuticals
  • DexCom
  • DICE Therapeutics
  • Elevation Oncology
  • Graybug
  • Impel Pharmaceuticals
  • Morphic Therapeutic
  • Nurix
  • Passage Bio
  • Prelude Therapeutics
  • Sema4
  • Stoke Therapeutics
  • Sutro Biopharma
  • Third Harmonic Bio

  • AnaptysBio
  • Day One Biopharmaceuticals
  • DexCom
  • DICE Therapeutics
  • Elevation Oncology
  • Graybug
  • Impel Pharmaceuticals
  • Morphic Therapeutic
  • Nurix
  • Passage Bio
  • Prelude Therapeutics
  • Sema4
  • Stoke Therapeutics
  • Sutro Biopharma
  • Third Harmonic Bio

  • Credit Suisse
  • Deutsche Bank
  • Goldman Sachs
  • J.P. Morgan
  • Morgan Stanley
  • Piper Sandler
  • UBS

  • Credit Suisse
  • Deutsche Bank
  • Goldman Sachs
  • J.P. Morgan
  • Morgan Stanley
  • Piper Sandler
  • UBS

  • Adaptive
  • AppLovin
  • Cloudflare
  • EngageSmart
  • Farfetch
  • Informatica
  • New Relic
  • Nutanix
  • Pivotal Software
  • TriNet
  • Zillow Group

  • Adaptive
  • AppLovin
  • Cloudflare
  • EngageSmart
  • Farfetch
  • Informatica
  • New Relic
  • Nutanix
  • Pivotal Software
  • TriNet
  • Zillow Group

  • Adesto Technologies
  • Alteryx
  • Amyris
  • Baozun
  • Barclays
  • BILL
  • Chegg
  • Cloudflare
  • Coinbase
  • DexCom
  • DocuSign
  • Goldman Sachs
  • Peloton
  • Proofpoint
  • Redfin
  • Snap
  • UpWork
  • Zillow Group
  • ZipRecruiter

  • Adesto Technologies
  • Alteryx
  • Amyris
  • Baozun
  • Barclays
  • BILL
  • Chegg
  • Cloudflare
  • Coinbase
  • DexCom
  • DocuSign
  • Goldman Sachs
  • Peloton
  • Proofpoint
  • Redfin
  • Snap
  • UpWork
  • Zillow Group
  • ZipRecruiter

Login

Don’t have an account yet?

Register